Ketalar

Ketamine, the active ingredient in Ketalar, is a NMDA receptor antagonist presented as a injectable solution for intramuscular and intravenous use. It provides dissociative anesthesia and analgesia for surgical procedures and other medical settings.

GNH USA supplies Ketalar as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ketalar (ketamine) is employed in clinical practice for anesthesia and related indications that involve NMDA receptor modulation.

- Induction of anesthesia: rapid onset of dissociative anesthesia for surgical start. - Maintenance of anesthesia: sustains anesthetic depth throughout operative procedures. - Sedation: produces controlled sedation for diagnostic or therapeutic interventions. - Analgesia: offers peri‑operative pain relief and reduces opioid requirements.

Ketalar may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Hypertension: transient elevation of blood pressure. - Tachycardia: increased heart rate during administration. - Nausea: feeling of sickness often accompanied by stomach discomfort. - Salivation: increased oral secretions. - Dizziness: sensation of light‑headedness or unsteadiness. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort requiring support. - Emergence delirium: vivid hallucinations or agitation during recovery. - Severe hypertension: potentially dangerous blood pressure spikes. - Cardiac arrhythmias: irregular heart rhythms that may be life‑threatening. - Allergic reactions: rash, itching, or anaphylaxis. - Neurotoxicity: rare cortical or urinary tract effects with prolonged exposure.

Ketalar should be used with careful clinical monitoring and adherence to safety protocols.

- Monitor cardiovascular status: observe blood pressure and heart rate continuously. - Assess airway patency: ensure a secure airway before and during administration. - Use in controlled setting: administer only by trained anesthesia personnel. - Evaluate psychiatric history: avoid or use cautiously in patients with psychosis or severe mental illness. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketalar can interact with other medications, altering its safety or efficacy.

Major Interactions (Avoid): - CNS depressants: may potentiate sedation and respiratory depression. - Sympathomimetics: can exacerbate hypertension and tachycardia. - MAO inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Opioids: additive analgesic effect may increase respiratory depression. - Benzodiazepines: may enhance sedative properties. - Alcohol: can amplify central nervous system effects.